LMR Partners’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$475K Hold
35,267
– – ﹤0.01% 1222
2026
Q2
$382K Hold
35,267
– – ﹤0.01% 1222
2026
Q1
$447K Hold
35,267
– – ﹤0.01% 1098
2025
Q4
$288K Hold
35,267
– – ﹤0.01% 1220
2025
Q3
$423K Hold
35,267
– – ﹤0.01% 1114
2025
Q2
$358K Sell
35,267
-33
-0.1% -$222 ﹤0.01% 1020
2025
Q1
$197K Buy
+35,300
New +$309K ﹤0.01% 1064
2023
Q2
– Sell
-23,780
Closed -$136K – 1051
2023
Q1
$136K Buy
+23,780
New +$124K ﹤0.01% 904
2022
Q4
– Sell
-11,277
Closed -$36K – 1222
2022
Q3
$36K Hold
11,277
– – ﹤0.01% 1127
2022
Q2
$51K Buy
+11,277
New +$45K ﹤0.01% 1157

Other funds holding ORIC

LMR Partners's ORIC Position: Q3 2026 in Review

LMR Partners held its Oric Pharmaceuticals (ORIC) position steady in Q3 2026 at 35,267 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

LMR Partners first reported a position in ORIC in Q2 2022 and has held it in 10 quarters since. 203 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • LMR Partners held 35,267 shares of Oric Pharmaceuticals worth $475K as of Q3 2026.
  • LMR Partners left its Oric Pharmaceuticals share count unchanged in Q3 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1222 holding.
  • LMR Partners first reported a position in Oric Pharmaceuticals in Q2 2022 and has held it in 10 quarters since.
  • 203 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.